Residual risk of hepatitis B virus transmission through blood donations in Burkina Faso screened with rapid diagnostic tests
Open Access
- 8 August 2022
- journal article
- research article
- Published by Wiley in Health Science Reports
- Vol. 5 (5) , e748
Abstract
Background and Aims: hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) represent the major transfusion–transmissible pathogens worldwide. The risk of transmission is relatively high in African countries, mainly due to unreliable screening methods of blood donations. In Burkina Faso, predonation screening using rapid diagnostic tests (RDTs) is widespread, raising the major question of the transfusion safety in the country. The objective of this study was to assess the risk of transmission of HBV, HCV, and HIV through blood transfusion in the context of the use of RDTs for screening of the blood donations.Methods: In this cross‐sectional study, a total of 417 serum samples obtained from blood donors tested negative for HBsAg, anti‐HCV, and anti‐HIV using RDTs were retested for the same markers using chemiluminescent immunologic assays. Total antibodies to HBV core (anti‐HBc) were tested on randomly selected samples. HBV‐DNA and HCV‐RNA viral loads (VLs) were quantified on HBsAg and anti‐HCV positive samples, respectively. To assess possible occult hepatitis B infection (OBI), HBV‐DNA‐VL was quantified on 313 randomly selected HBsAg‐negative samples.Results: HBsAg and anti‐HCV were found respectively in 6 (6/417; 1.4%) and 11 (11/417; 2.6%) samples. No samples were reactive for anti‐HIV. Total anti‐HBc were detected in 217 out of the 319 randomly selected samples (217/319; 68.02%). HBV‐DNA was detected in four (4/313; 1.27%) samples, including two (2/6; 33.33%) of the six HBsAg positive samples and two (2/313; 0.6%) of the HBsAg‐negative samples, suggesting two cases of occult HBV infection. All anti‐HCV antibody‐positive samples were HCV‐RNA negative.Conclusion: This study shows that RDTs are not sufficiently sensitive for the screening of blood donations. Our results highlight the urgent need to think about the extension of sensitive immunological tests in all blood transfusion centers and also the implementation of nucleic acid amplification techniques.Keywords
This publication has 26 references indexed in Scilit:
- Risk factors associated with hepatitis B exposure and the reliability of five rapid kits commonly used for screening blood donors in GhanaBMC Research Notes, 2014
- Preoperative assessment and treatment of appendiceal mucocele complicated by acute torsion: a case reportBMC Research Notes, 2014
- Occult hepatitis B virus infection among Egyptian blood donorsWorld Journal of Hepatology, 2013
- Multinational assessment of blood‐borne virus testing and transfusion safety on the African continentTransfusion, 2012
- Blood Transfusion Safety in Africa: A Literature Review of Infectious Disease and Organizational ChallengesTransfusion Medicine Reviews, 2012
- Seroprevalence and incidence of transfusion‐transmitted infectious diseases among blood donors from regional blood transfusion centres in Burkina Faso, West AfricaTropical Medicine & International Health, 2011
- Hepatitis B, hepatitis C and HIV transfusion‐transmitted infections in the 21st centuryVox Sanguinis, 2010
- Blood safety in Sub‐Saharan Africa: a multi‐factorial problemTransfusion, 2008
- Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource‐poor settingsTransfusion, 2005
- The risk of hepatitis B virus infection by transfusion in Kumasi, GhanaBlood, 2003